Wadden TA - Search Results

1

The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it.

Look AHEAD Research Group; Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, Berkowitz RI, Kelley DE, Tomchee C, Hill JO, Kumanyika S. Look AHEAD Research Group, et al. Among authors: wadden ta. Obesity (Silver Spring). 2006 May;14(5):737-52. doi: 10.1038/oby.2006.84. Obesity (Silver Spring). 2006. PMID: 16855180 Free PMC article. Review.

2

Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective.

Wadden TA, Sternberg JA, Letizia KA, Stunkard AJ, Foster GD. Wadden TA, et al. Int J Obes. 1989;13 Suppl 2:39-46. Int J Obes. 1989. PMID: 2613427 Clinical Trial.

3

Binge eating disorder and the night-eating syndrome.

Stunkard A, Berkowitz R, Wadden T, Tanrikut C, Reiss E, Young L. Stunkard A, et al. Int J Obes Relat Metab Disord. 1996 Jan;20(1):1-6. Int J Obes Relat Metab Disord. 1996. PMID: 8788315

4

Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite, and mood.

Wadden TA, Vogt RA, Andersen RE, Bartlett SJ, Foster GD, Kuehnel RH, Wilk J, Weinstock R, Buckenmeyer P, Berkowitz RI, Steen SN. Wadden TA, et al. J Consult Clin Psychol. 1997 Apr;65(2):269-77. doi: 10.1037//0022-006x.65.2.269. J Consult Clin Psychol. 1997. PMID: 9086690 Clinical Trial.

5

Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach.

Wadden TA, Berkowitz RI, Vogt RA, Steen SN, Stunkard AJ, Foster GD. Wadden TA, et al. Obes Res. 1997 May;5(3):218-26. doi: 10.1002/j.1550-8528.1997.tb00296.x. Obes Res. 1997. PMID: 9192396 Free article. Clinical Trial.

6

The fen-phen finale: a study of weight loss and valvular heart disease.

Wadden TA, Berkowitz RI, Silvestry F, Vogt RA, St John Sutton MG, Stunkard AJ, Foster GD, Aber JL. Wadden TA, et al. Obes Res. 1998 Jul;6(4):278-84. doi: 10.1002/j.1550-8528.1998.tb00350.x. Obes Res. 1998. PMID: 9688104 Free article.

7

Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions.

Wadden TA, Anderson DA, Foster GD. Wadden TA, et al. Obes Res. 1999 Mar;7(2):170-8. doi: 10.1002/j.1550-8528.1999.tb00699.x. Obes Res. 1999. PMID: 10102254 Free article. Clinical Trial.

8

Valvular heart disease in fenfluramine- phentermine-treated patients: a comparison with control patients.

Wadden TA, Silvestry FE, Aber JL, Berkowitz RI, Foster GD, Sutton MG. Wadden TA, et al. Obes Res. 1999 May;7(3):309-10. doi: 10.1002/j.1550-8528.1999.tb00412.x. Obes Res. 1999. PMID: 10348504 Free article. No abstract available.

9

Behavioural treatment of the overweight patient.

Wadden TA, Sarwer DB, Berkowitz RI. Wadden TA, et al. Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Apr;13(1):93-107. doi: 10.1053/beem.1999.0008. Baillieres Best Pract Res Clin Endocrinol Metab. 1999. PMID: 10932678 Review.

10

Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.

Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM. Wadden TA, et al. Obes Res. 2000 Sep;8(6):431-7. doi: 10.1038/oby.2000.53. Obes Res. 2000. PMID: 11011909 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page